Surviving breast cancer is certainly its own reward, but a new study finds that many who do are saddled with thousands in out-of-pocket expenses for years.
For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests.
A magnetic system for guiding lymph node biopsies in certain people with breast cancer has been approved by the U.S. Food and Drug Administration.
The cost of treatment for early stage breast cancer can be devastating for many patients, but they get little guidance or help from their doctors, a new study suggests.
Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.
For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease.
Much of the debate over when to start having mammograms has focused on lives saved, but new research suggests that early screening might also translate into smaller tumors and less aggressive breast cancer treatments.
While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.
A new type of MRI (magnetic resonance imaging) that doesn't use a contrast agent appears better at detecting what's really cancer and what's likely just a harmless lesion, researchers report.
In what researchers call a first step toward personalized vaccines for a multitude of cancers, a vaccine made from stem cells protected mice from tumors.
Older women who carry some extra body fat may face a heightened risk of breast cancer -- even if their weight is normal, a new study finds.
Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals.
It's never too late for women to lose weight to lower their breast cancer risk, a new study suggests.
Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows.
Machines armed with artificial intelligence may one day help doctors better identify high-risk breast lesions that might turn into cancer, new research suggests.
Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends.
Waiters, contractors and other employees of America's small businesses are more likely to miss out on cancer screening, mostly because of a lack of insurance, new research shows.
Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows.
Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.
Scientists say they've spotted how mutations in the BRCA1 gene can trigger breast cancer.
New research finds the number of American women who've lost their lives to breast cancer has fallen precipitously in the past 25 years, with more than 322,000 lives saved in that time.
Verzenio (abemaciclib) has been approved by the U.S. Food and Drug Administration to treat women with certain advanced forms of breast cancer, the most common cancer in the United States.